Company / Revenue per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.42
FY2025
5-year range
$13.63 / $15.42
FY2021-FY2025
Trend
+3.5%
vs FY2024
Sector context
#32 of 154
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's revenue per share of $15.42 is higher than 79% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 3 consecutive years, from $13.63 in FY2022 to $15.42 in FY2025.
Based on SEC 10-K filings.
15.42 in FY2025 with a 5-year CAGR of -1.1%. Top quartile in the Health Care sector.
Improved from $14.31 to $15.42 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Sector benchmark
+49.0% above sector average
Key checks
Key Insights
- TEVA PHARMACEUTICAL INDUSTRIES LTD's revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 3.5% year-over-year.
- Ranks #32 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.42 | +3.5% |
| FY2024 | $14.90 | +4.1% |
| FY2023 | $14.31 | +5.0% |
| FY2022 | $13.63 | -6.3% |
| FY2021 | $14.55 | -10.8% |
| FY2020 | $16.32 | -1.8% |
| FY2019 | $16.62 | -100.0% |
| FY2018 | $19012486.99 | +88393652.7% |
| FY2017 | $21.51 | -100.0% |
| FY2016 | $22791883.45 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026